Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Protective effect of single-dose salbutamol against exercise-induced inspiratory airflow obstruction in asthmatic children
2013-002769-20Phase 4Active
- Sponsor
- Medisch Spectrum Twente
- Start
- Jul 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, single-arm trial of salbutamol in exercise-induced bronchospasm (EIB) and asthma, sponsored by Medisch Spectrum Twente. Started Jul 2013; status: active.
02
Drugs
salbutamol
03
Conditions
exercise-induced bronchospasm (EIB)asthma
Beyond the preview
Go deeper on 2013-002769-20.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-002769-20.